Cash and cash equivalents were $39.6 million as of January 27, 2023, compared to $34.3 million as of January 28, 2022. Net cash used in operations was $36.4 million for the 52 weeks ended January 27, 2023, compared to net cash provided by operations of $70.6 m...
End of term report for CMOdoi:10.1136/bmj.323.7307.280BMJDonnelly
Gross profit reached a record$1.9 billionfor the year endedDecember 31, 2022, a 20% increase over gross profit of$1.6 billionin 2021. Gross margin improved 80 basis points to 31.3% in 2022 compared to 30.5% in 2021, reflecting benefits from acquisitions, increased pricing and supply...
2022 fan attendance of 5.7 million, up 36% compared to 2019 Cumulative TV viewers of 1.54 billion in 2022 Social media followers up 23% to 61 million Cumulative TV viewership in US up 36% Secured Qatar Airways as Global Airline Partner under multi-year agreement Re...
Other long-term liabilities 71,007 101,736 Total liabilities 6,402,493 6,324,271 Common stock, $.01 par value, 800,000,000 shares authorized; 261,610,518 and 261,348,030 shares issued at year-end 2022 and year-end 2021, respectively; 236,469,365 and 243,675,522 ...
Net income of $21.8 million and diluted earnings per share of $3.58 for the year ended December 31, 2022, and net income of $4.6 million and diluted earnings per share of $0.77 for the fourth quarter ended December 31, 2022. Return on average assets and
and management expects that it will remain near that level for the second half of the year. Operating expenditures were elevated due to several factors, but management reiterated its belief that it will reach its goal for the medium term, aided by its anticipated savings of CHF 650 million fro...
Qualigen Therapeutics, Inc. (Nasdaq: QLGN Qualigen Therapeutics, Inc.) today announces financial results for the fourth quarter and fiscal year ended December 31, 2022, and provides an update on the company’s therapeutics pipeline and other corporate ...
“2022 was a challenging year for the company. We faced downstream impacts from the December 2021 fire at our Rocky Mount fulfillment center throughout the year, while also experiencing macro pressure that impacted consumer demand,” said David Rawlinson, President and CEO...
Introduces Fiscal 2023 Guidance and Maintains its Long-term Projected Growth Rate WALL, N.J.--(BUSINESS WIRE)-- Today, New Jersey Resources Corporation (NYSE: NJR) reported results for the fourth quarter and year ended fiscal 2022. Highlights include: Consolid...